SI2188268T1 - Substituirani piperazinil pirazini in piridini kot antagonisti 5-ht7 receptorja - Google Patents
Substituirani piperazinil pirazini in piridini kot antagonisti 5-ht7 receptorjaInfo
- Publication number
- SI2188268T1 SI2188268T1 SI200830392T SI200830392T SI2188268T1 SI 2188268 T1 SI2188268 T1 SI 2188268T1 SI 200830392 T SI200830392 T SI 200830392T SI 200830392 T SI200830392 T SI 200830392T SI 2188268 T1 SI2188268 T1 SI 2188268T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pyridines
- receptor antagonists
- substituted piperazinyl
- pyrazines
- piperazinyl pyrazines
- Prior art date
Links
- HCGFLVDMFDHYJD-UHFFFAOYSA-N 2-piperazin-1-ylpyrazine Chemical class C1CNCCN1C1=CN=CC=N1 HCGFLVDMFDHYJD-UHFFFAOYSA-N 0.000 title 1
- 108091005436 5-HT7 receptors Proteins 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96834407P | 2007-08-28 | 2007-08-28 | |
| US4875208P | 2008-04-29 | 2008-04-29 | |
| EP08798144A EP2188268B1 (en) | 2007-08-28 | 2008-08-19 | Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| PCT/US2008/073543 WO2009029439A1 (en) | 2007-08-28 | 2008-08-19 | Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2188268T1 true SI2188268T1 (sl) | 2011-11-30 |
Family
ID=39873874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200830392T SI2188268T1 (sl) | 2007-08-28 | 2008-08-19 | Substituirani piperazinil pirazini in piridini kot antagonisti 5-ht7 receptorja |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8048884B2 (sl) |
| EP (1) | EP2188268B1 (sl) |
| JP (1) | JP5290293B2 (sl) |
| KR (1) | KR101148616B1 (sl) |
| CN (1) | CN101790522B (sl) |
| AR (1) | AR068111A1 (sl) |
| AT (1) | ATE520673T1 (sl) |
| AU (1) | AU2008293715B2 (sl) |
| BR (1) | BRPI0816468A2 (sl) |
| CA (1) | CA2694911C (sl) |
| CY (1) | CY1111848T1 (sl) |
| DK (1) | DK2188268T3 (sl) |
| EA (1) | EA017809B1 (sl) |
| HR (1) | HRP20110624T1 (sl) |
| MX (1) | MX2010002352A (sl) |
| PE (1) | PE20090629A1 (sl) |
| PL (1) | PL2188268T3 (sl) |
| PT (1) | PT2188268E (sl) |
| SI (1) | SI2188268T1 (sl) |
| TW (1) | TW200914020A (sl) |
| WO (1) | WO2009029439A1 (sl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI118473B (fi) | 2006-02-17 | 2007-11-30 | Outotec Oyj | Menetelmä kuparin talteenottamiseksi kuparisulfidimalmista |
| ES2380756T3 (es) * | 2007-10-12 | 2012-05-18 | Eli Lilly And Company | Antagonistas del receptor 5-HT7 |
| ES2651002T3 (es) | 2010-04-16 | 2018-01-23 | Bayer Intellectual Property Gmbh | Nuevos compuestos heterocíclicos como pesticidas |
| KR20140075783A (ko) | 2011-10-11 | 2014-06-19 | 유씨비 파마, 에스.에이. | 2옥소피페리디닐 유도체 |
| FR2995605B1 (fr) | 2012-09-18 | 2014-09-19 | Sanofi Sa | Derives de macrolides, leur preparation et leur application therapeutique. |
| CN105829287B (zh) | 2013-12-20 | 2019-08-27 | 埃斯蒂文制药股份有限公司 | 具有抗疼痛的多重模式活性的哌嗪衍生物 |
| CN110475773A (zh) | 2017-03-03 | 2019-11-19 | 琳达·佳慧·余 | 8-苯基异喹啉及其医药组合物用于治疗肠易激综合征 |
| KR102014335B1 (ko) * | 2017-12-01 | 2019-08-26 | 한국과학기술연구원 | 5-ht7 수용체의 조절제로 작용하는 아릴피라졸릴피페라진 또는 아릴피라졸릴다이아제페인의 유도체 및 이를 포함하는 중추신경계 질환 치료 또는 예방용 약학 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2360164A1 (en) * | 1999-02-10 | 2000-08-17 | Eli Lilly And Company | 5-ht1f agonists |
| US20030008880A1 (en) * | 2001-05-02 | 2003-01-09 | Pfizer Inc. | 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity |
| MXPA05008137A (es) * | 2003-01-31 | 2005-09-30 | Pfizer Prod Inc | Antagonistas y agonistas de 5ht7. |
| US7153858B2 (en) * | 2003-01-31 | 2006-12-26 | Epix Delaware, Inc. | Arylpiperazinyl compounds |
-
2008
- 2008-08-01 TW TW097129418A patent/TW200914020A/zh unknown
- 2008-08-19 MX MX2010002352A patent/MX2010002352A/es active IP Right Grant
- 2008-08-19 CA CA2694911A patent/CA2694911C/en not_active Expired - Fee Related
- 2008-08-19 EA EA201070321A patent/EA017809B1/ru not_active IP Right Cessation
- 2008-08-19 PL PL08798144T patent/PL2188268T3/pl unknown
- 2008-08-19 JP JP2010523034A patent/JP5290293B2/ja not_active Expired - Fee Related
- 2008-08-19 PT PT08798144T patent/PT2188268E/pt unknown
- 2008-08-19 WO PCT/US2008/073543 patent/WO2009029439A1/en active Application Filing
- 2008-08-19 BR BRPI0816468 patent/BRPI0816468A2/pt not_active Application Discontinuation
- 2008-08-19 DK DK08798144.5T patent/DK2188268T3/da active
- 2008-08-19 US US12/447,546 patent/US8048884B2/en not_active Expired - Fee Related
- 2008-08-19 EP EP08798144A patent/EP2188268B1/en not_active Not-in-force
- 2008-08-19 CN CN2008801048354A patent/CN101790522B/zh not_active Expired - Fee Related
- 2008-08-19 AT AT08798144T patent/ATE520673T1/de active
- 2008-08-19 AU AU2008293715A patent/AU2008293715B2/en not_active Ceased
- 2008-08-19 KR KR1020107004378A patent/KR101148616B1/ko not_active IP Right Cessation
- 2008-08-19 SI SI200830392T patent/SI2188268T1/sl unknown
- 2008-08-27 PE PE2008001449A patent/PE20090629A1/es not_active Application Discontinuation
- 2008-08-27 AR ARP080103721A patent/AR068111A1/es unknown
-
2011
- 2011-08-30 HR HR20110624T patent/HRP20110624T1/hr unknown
- 2011-09-20 CY CY20111100910T patent/CY1111848T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL2188268T3 (pl) | 2011-12-30 |
| MX2010002352A (es) | 2010-08-04 |
| EA201070321A1 (ru) | 2010-08-30 |
| EP2188268B1 (en) | 2011-08-17 |
| WO2009029439A1 (en) | 2009-03-05 |
| CY1111848T1 (el) | 2015-10-07 |
| JP5290293B2 (ja) | 2013-09-18 |
| AU2008293715B2 (en) | 2013-09-19 |
| KR101148616B1 (ko) | 2012-05-21 |
| CA2694911A1 (en) | 2009-03-05 |
| EP2188268A1 (en) | 2010-05-26 |
| CN101790522B (zh) | 2012-06-27 |
| JP2010537994A (ja) | 2010-12-09 |
| EA017809B1 (ru) | 2013-03-29 |
| CN101790522A (zh) | 2010-07-28 |
| ATE520673T1 (de) | 2011-09-15 |
| US8048884B2 (en) | 2011-11-01 |
| BRPI0816468A2 (pt) | 2015-03-24 |
| PE20090629A1 (es) | 2009-05-16 |
| PT2188268E (pt) | 2011-10-03 |
| DK2188268T3 (da) | 2011-10-03 |
| KR20100038117A (ko) | 2010-04-12 |
| AR068111A1 (es) | 2009-11-04 |
| CA2694911C (en) | 2013-05-07 |
| HRP20110624T1 (hr) | 2011-09-30 |
| US20100075976A1 (en) | 2010-03-25 |
| TW200914020A (en) | 2009-04-01 |
| AU2008293715A1 (en) | 2009-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2188268E (pt) | Piperazinil-piperazinas e piridinas substituídas como antagonistas do recetor 5-ht7 | |
| SI2001849T1 (sl) | Derivati piridina in pirimidina kot antagonisti mglur2 | |
| BRPI0817245A2 (pt) | Derivados e quinolina como antagonistas receptores de 5ht5a | |
| PL2155717T3 (pl) | 2-[4-(PIRAZOL-4-ILOALKILO)PIPERAZYN-1-YLO]-3-FENYLO PIRAZYNY I PIRYDYNY I 3-[4-(PIRAZOL-4-ILOALKILO)PIPERAZYN-1-YLO]-2-FENYLO PIRYDYNY JAKO ANTAGONIŚĆI RECEPTORA 5-HT<sub>7</sub> | |
| PT2129654E (pt) | Antagonistas do receptor de glucagina | |
| IL225521A0 (en) | 1trpv antagonists and their uses | |
| IL200780A0 (en) | Pyridine and pyrimidine derivatives as mglur2 antagonists | |
| EP2161996A4 (en) | CGRP RECEPTOR ANTAGONISTS BASED ON HETEROCYCLIC CARBOXAMIDE | |
| ZA201100866B (en) | Tripyridyl carboxamide orexin receptor antagonists | |
| EP2438041A4 (en) | PYRAZINE-carboxamide-orexin receptor Antagonist | |
| EP2131654A4 (en) | BIPYRIDINE CARBOXAMIDES, ANTAGONISTS OF THE OREXIN RECEPTOR | |
| IL215690A0 (en) | Thiazole derivatives and their use as p2y12 receptor antagonists | |
| ZA201000395B (en) | Substituted piperazines as cb1 antagonists | |
| ZA200900303B (en) | Cinnamoyl-piperazine derivatives and their use as par-i antagonists | |
| ZA200903574B (en) | 2-Phenyl-6-Aminocarbonyl-Pyrimidine derivatives and their use as P2Y12 Receptor antagonists | |
| HK1158640A1 (en) | Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists 5-ht6 6-(1-)- | |
| EP2654423A4 (en) | AZAINDANE ANTAGONISTS HETEROCYCLIC CARBOXAMIDES MERGED FROM CGRP RECEPTORS | |
| EP2125724A4 (en) | NAPHTHALENE DERIVATIVES AND QUINOLINE SULFONYLUREA AS ANTAGONISTS OF THE EP4 RECEPTOR | |
| IL215483A0 (en) | Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide | |
| IL205749A0 (en) | Modified il-4 mutein receptor antagonists | |
| HK1179619A1 (en) | (3 -methylpyrrolidin- 3 - yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists (3---3-)- nk-3 | |
| IL199439A0 (en) | Pyridine compounds and their use as p2y12 antagonists | |
| ZA201002171B (en) | 2-s-benzyl substituted pyrimidines as crth2 antagonists | |
| IL223060A0 (en) | Nicotinic receptor non-competitive antagonists | |
| SI2155717T1 (sl) | 2-(4-(pirazol-4-ilalkil)piperazin-1-il)-3-fenil pirazini in piridini ter 3-(4(pirazol-4-ilalkil)piperazin-1-il)-2-fenil piridini kot antagonisti 5-ht7 receptorja |